About this Event
Cutting the size of osteoporosis trials from 15,000 to 500: Bone Mineral Density as an FDA-qualified, surrogate endpoint to replace fracture in future RCTs
Dennis M. Black, PhD. Professor of Epidemiology, Biostatistics. University of California San Francisco.
Please let us know if you require an accommodation in order to participate in this event. Accommodations may include live captioning, ASL interpreters, and/or captioned media and accessible documents from recorded events. At least 5 days in advance is recommended.
